8:00 am - 8:45 am

Breakfast

8:45 am - 9:00 am

Welcome and Opening Remarks

9:00 am - 10:45 am Session 1: Neurobiologically-derived Biomarkers and Mechanistically Targeted Interventions in Neurodevelopmental Conditions

9:00 am - 9:30 am - Dr. Lauren Ethridge
Translating sensory EEG phenotypes in Fragile X Syndrome (FXS): validating biomarkers from mouse to human to enable clinical trials

9:30 am - 10:00 am - Dr. Christine Conelea
Targeted engagement of Tourette-related neurocircuitry with TMS to augment behavior therapy

10:00 am - 10:30am - Dr. Christian Cazares
Aperiodic activity as a candidate marker of cortical dysfunction in Rett syndrome EEG and Mecp2+/- mouse visual cortex

10:30 am - 10:45 am - Session 1 Discussion Panel

10:45 am - 11:00 am

Break

11:00 am - 12:45 pm - Session 2: Neural Oscillations and Network Synchrony: From Circuit Mechanisms to Biomarkers in Autism and Related Neurodevelopmental Disorders

11:00 am - 11:30 am - Dr. Shlomit Beker
From Neural Synchrony to Clinical Biomarkers

11:30 am - 12:00 pm - Dr. Sophie Molholm
Beyond Sensory Encoding: Altered Feedback Shapes Perception in Autism

12:00 pm - 12:30 pm - Dr. Tal Kenet
Synchronization as a Window into the Neural Mechanisms Underlying Autism

12:30 pm - 12:45 pm - Session 2 Discussion Panel

12:45 pm - 1:45 pm

Lunch

1:45 pm - 2:15 pm

ECNS Presidential Lecture – Dr. M. Kemal Arikan

2:15 pm - 4:15 pm Session 3: Trainee and Early Career Investigators Session

2:15 pm – 3:15 pm - Flash Talks

3:15 pm – 4:15 pm - Poster Session

4:15 pm - 5:30 pm: Keynote Speaker

Dr.  Adrianna Di Martino

8:30 am - 9:00 am

Breakfast

9:00 am - 10:45 am Session 4: Psychosis

9:00 am – 9:30 am - Dr. Brian Keane
Thalamic and cortical sensory dysconnectivity as a biomarker for psychosis

9:30 am – 10:00 am - TBD

10:00 am – 10:30 am - Dr. Steven Silverstein
Retinal neural and vascular changes in psychotic and mood disorders

10:30 am – 10:45 am - Session 4   Discussion Panel

10:45 am - 11:00 am

Break

11:00 am - 12:45 pm Session 5: Targeting Brain Stimulation – The When and the Where

11:00 am – 11:30 am - Dr. Ivan Alekseichuk
Physiological and behavioral roles of EEG phase through the lens of transcranial magnetic stimulation

11:30 pm – 12:00 pm  - Dr. Eric Rawls
Using multimodal neuroimaging to isolate and target a human neurocomputational mechanism driving enhanced expected value of control

12:00 pm – 12:30 pm - Dr. Simon Davis
Modulating memory representations in aging and disease

12:30 pm – 12:45 pm - Session 5 Discussion Panel

12:45 pm - 2:00 pm

Lunch

2:00 pm - 3:45 pm Session 6: EEG-Derived Markers to Characterize and Treat Drug Use

2:00 pm – 2:30 pm - Dr. Derek Fisher
Interaction between caffeine and menstrual cycle phase on EEG-indexed sustained attention

2:30 pm – 3:00 pm - Dr. Salvatore Campanella
Cognitive ERPs in substance use disorders

3:00 pm – 3:30 pm - Dr. Tanju Surmeli
QEEG Guided Neurofeedback is effective and reduces relapses as a stand-alone therapy in Substance Use Disorders

3:30 pm – 3:45 pm - Session 3 Discussion Panel

3:45 pm - 4:15 pm

Break

4:15 pm - 5:30 pm: Keynote Speaker

Dr. Bernadette Gillick
Understanding Recovery and Development after Early Brain Injury using Neuromodulation

6:00 pm - 9:00 pm: Dinner Reception

Jackrabbit Club
40 Anderson Avenue
Rochester, NY

8:30 am - 9:00 am

Breakfast

9:00 am - 10:45 am Session 7: Bridging the Gap Between Research and Clinical Practice: Implications of Intracranial Electroencephalography

9:00 am – 9:30 am - Dr. Tonmoy Monsoor
Bridging Research and Practice in Intracranial EEG: Omni-iEEG for Epilepsy Biomarker Discovery

9:30 am – 10:00 am - Dr. Adeen Flinker
Neural dynamics of feedforward and feedback speech processing

10:00 am – 10:30 am - Dr. Frank Garcea
Advances in translational brain mapping at URMC

10:30 am – 10:45 am - Session 7 Discussion Panel

10:45 am - 11:00 am

Break

11:00 am - 12:45 pm Session 8: EEG Biomarkers of Predictive Processing in Psychosis and its At-Risk State

11:00 am – 11:20 am - Dr. Michael Kiang
P2 visual semantic priming effects predict two-year clinical outcomes in patients at clinical high risk for psychosis

11:20 am – 11:40am - Dr. Molly Erickson
Divergence between mismatch negativity (MMN) deficits and clinical symptoms in schizophrenia

11:40 am – 12:00 pm - Dr. Victor Pokorny
Alpha Peak Frequency in Individuals at Clinical High-Risk for Psychosis

12:00 pm – 12:20 pm - Dr. Brian Coffman
Effects of Attention on Perceptual Grouping and Segmentation of Auditory Stimuli in First Episode Psychosis

12:20 pm – 12:45 pm - Session 8 Discussion Panel

12:45 pm - 2:00 pm

Lunch

2:00 pm - 3:45 pm Session 9: Bridging the Gap Between Research and Clinical Practice: Implications of intracranial Electroencephalography

2:00 pm – 2:30 pm - Dr. Kathryn Toffolo
Developing a sense of meaning: How children with and without autism comprehend semantics across development

2:30 pm – 3:00 pm - Dr. Mark Pflieger
Using individual structural MRI and group fMRI to benchmark and improve distributed localization of ERP cortical sources

3:00 pm – 3:30 pm - Dr. Pierfilippo DeSanctis
Neural Signatures of Complex Daily Activities in Older Adults at Risk for Cognitive Decline

3:30 pm – 3:45 pm - Session 9 Discussion Panel

3:45 pm - 4:00 pm

Break

4:00 pm - 5:15 pm: Keynote Speaker

Dr. Lisa Maffie
Honoring Loss and Driving Discovery: Risk, Research, and the Fight to End SUDEP (Sudden Unexpected Death in Epilepsy)

5:15 pm - 5:20 pm

Closing Remarks